SUNDARAM PREETHI (Chief Product Devel. Officer) exercised options at CATALYST PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 12/10/2025ACC: 0001161697-25-000449
Officer· Chief Product Devel. Officer
Since Jul 2021
-1.67K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
6.86K acquired · 8.52K disposed
Non-Derivative Transactions2
Common Stock, par value $0.001 per share
Direct
Shares
+6.86K
Price / share
—
Trade value
—
% of position
15.1%
12/8/2025
45.32K→52.17K
Common Stock, par value $0.001 per share
Direct
Shares
−1.67K
Price / share
—
Trade value
—
% of position
3.2%
12/8/2025
52.17K→50.51K
Total
Net shares
+5.19K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Direct | 12/8/2025 | M · Option Exercise | +6.86K | — | — | 15.1% | 45.32K | 52.17K |
| Common Stock, par value $0.001 per share Direct | 12/8/2025 | F · Tax Withholding | −1.67K | — | — | 3.2% | 52.17K | 50.51K |
| Total | +5.19K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.86K shares
Shares
−6.86K
Strike price
Held after
805.10K
Exercisable
—
12/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.86K shares | 12/8/2025 | M · Option Exercise | −6.86K | — | 805.10K |